Too much or too little: harnessing senescence to control oncogene-driven cancer
- PMID: 22894904
- PMCID: PMC3466506
- DOI: 10.4161/cc.21588
Too much or too little: harnessing senescence to control oncogene-driven cancer
Figures
Comment in
- Astle MV, Hannan KM, Ng PY, Lee RS, George AJ, Hsu AK, Haupt Y, Hannan RD, Pearson RB. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene. 2012;31:1949–62. doi: 10.1038/onc.2011.394.
Similar articles
-
Oncogene-induced senescence pathways weave an intricate tapestry.Cell. 2007 Jan 26;128(2):233-4. doi: 10.1016/j.cell.2007.01.005. Cell. 2007. PMID: 17254959 Review.
-
Oncogene-induced senescence: a double edged sword in cancer.Acta Pharmacol Sin. 2018 Oct;39(10):1553-1558. doi: 10.1038/aps.2017.198. Epub 2018 Apr 5. Acta Pharmacol Sin. 2018. PMID: 29620049 Free PMC article. Review.
-
Nucleotide metabolism, oncogene-induced senescence and cancer.Cancer Lett. 2015 Jan 28;356(2 Pt A):204-10. doi: 10.1016/j.canlet.2014.01.017. Epub 2014 Jan 29. Cancer Lett. 2015. PMID: 24486217 Free PMC article. Review.
-
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.EMBO J. 2012 Jun 29;31(13):2839-51. doi: 10.1038/emboj.2012.132. Epub 2012 May 8. EMBO J. 2012. PMID: 22569128 Free PMC article.
-
If you can't beat me, join me: collaborating oncogenes circumventing senescence and causing cancer.Pigment Cell Melanoma Res. 2011 Aug;24(4):586-7. doi: 10.1111/j.1755-148x.2011.00883.x. Pigment Cell Melanoma Res. 2011. PMID: 22489324 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources